MedPath

The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis

Completed
Conditions
Acute Appendicitis
Registration Number
NCT01652170
Lead Sponsor
Venaxis, Inc.
Brief Summary

This study will consist of a brief interaction with the subject or parent or guardian to obtain consent, collect a blood sample, medical history, and physical examination of those who meet the inclusion criteria. The blood sample will be tested for the WBC value, as well as processed into plasma in order to compute the APPY1 Test result, which is based on a combination of the WBC value and the plasma MRP 8/14 and CRP concentrations received from the APPY1 Test cassette. There will be a 2-week (14 days +/- 3) follow-up telephone call for those subjects that were discharged from the ED without an appendectomy or diagnosis of acute appendicitis. Use of the APPY1 Test to help identify low risk patients could significantly reduce the use of CT scans in diagnosis of AA, thereby reducing the exposure to ionizing radiation in children, adolescents, and young adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2201
Inclusion Criteria
  • 2 to 20 years old (up until the 21st birthday),
  • Right lower quadrant or poorly localized abdominal pain, or tenderness that includes the right lower quadrant, and/or other features including, but not limited to, nausea, vomiting, and/or anorexia, requiring acute appendicitis to be added to the differential,
  • Onset of abdominal pain within 72 hours or less,
  • Patients of either gender may participate and,
  • Patient or accompanying parent or guardian is able to provide informed consent.
Exclusion Criteria
  • History includes prior appendectomy,
  • Subjects whose presentation history and physical examination place them at such high risk of acute appendicitis that it would be clinically reasonable to proceed with exploratory laparotomy and/or appendectomy without advanced imaging,
  • Treatment with any immunosuppressive medication or chemotherapeutic agents within 28 days, or systemic steroids (oral or intravenous) within 14 days,
  • History of end-stage, metastatic cancer or an active immune disorder,
  • History includes abdominal trauma or invasive abdominal procedures/surgery within the previous two weeks,
  • Patients who have received diagnostic imaging (CT, MRI, or US) for abdominal pain in the previous two weeks,
  • Patients with report of abdominal pain greater than 72 hours,
  • History of active bleeding disorder, which may complicate phlebotomy or placement of peripheral IV catheter,
  • Participation in a research study within the previous 30 days,
  • Prisoners of an adult or juvenile detention center, and
  • Subject, parent or guardian unable to provide informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity, Specificity, Negative and Positive Predictive ValueUpon 3rd party review of data

95% confidence intervals on Sensitivity and Specificity

Secondary Outcome Measures
NameTimeMethod
CT utilizationUpon 3rd party review of data

CT utilization behaviors based on questions posed to the physicians about their current imaging intentions and those intentions were an APPY1 Test result available

Trial Locations

Locations (29)

Children's National Medical Center

🇺🇸

Washington, District of Columbia, United States

Spectrum Health System

🇺🇸

Grand Rapids, Michigan, United States

UC Davis

🇺🇸

Sacramento, California, United States

Phoenix Children's Hosptial

🇺🇸

Phoenix, Arizona, United States

Scottish Rite (CHOA)

🇺🇸

Atlanta, Georgia, United States

Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

Emory-Egleston (CHOA)

🇺🇸

Atlanta, Georgia, United States

University of Florida, College of Medicine

🇺🇸

Jacksonville, Florida, United States

All Children's Hospital

🇺🇸

St. Petersburg, Florida, United States

Newton-Wellesley Hospital

🇺🇸

Newton, Massachusetts, United States

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

South Shore Hospital

🇺🇸

Weymouth, Massachusetts, United States

University of Michigan, Mott Children's Hospital

🇺🇸

Ann Arbor, Michigan, United States

The Children's Mercy Hosptial

🇺🇸

Kansas City, Missouri, United States

OHSU

🇺🇸

Portland, Oregon, United States

Staten Island University Hospital

🇺🇸

Staten Island, New York, United States

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Wake Forest Baptist Health

🇺🇸

Winston-Salem, North Carolina, United States

Cincinnati Children's Hospital

🇺🇸

Cincinnati, Ohio, United States

Nationwide Children's

🇺🇸

Columbus, Ohio, United States

Rhode Island Hospital - Hasbro

🇺🇸

Providence, Rhode Island, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Children's Hospital of Pittsburg

🇺🇸

Pittsburg, Pennsylvania, United States

St. Joseph's Regional Health Center

🇺🇸

Bryan, Texas, United States

St. Joseph's Emergency Center

🇺🇸

College Station, Texas, United States

Dallas Children's Hospital

🇺🇸

Dallas, Texas, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Vanderbilt Children's Hospital

🇺🇸

Nashville, Tennessee, United States

Dell Children's Medical Center

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath